California Telehealth Network Announces Partnership with HealthFusion MediTouch® EHR

SACRAMENTO, Calif. & SOLANA BEACH, Calif.--The California Telehealth Network (CTN) and HealthFusion, Inc., announced today that HealthFusion’s MediTouch Electronic Health Record is the first electronic health records partner for the California Telehealth Network. This new partnership supports the CTN mission of increasing access to healthcare through advanced information technology, with an emphasis on rural and medically underserved areas of California.

MediTouch, an award winning cloud-based EHR that is 2014 Meaningful Use certified and ICD-10 ready, is available for CTN members at a discount and with special benefits.

"As our small and independent practice providers face the challenges of complying with Stage 2 Meaningful Use requirements, HealthFusion provides an affordable cloud based electronic health record solution created by doctors, for doctors,” said CTN President and CEO Eric Brown.

MediTouch is a total medical software solution with EHR, Practice Management, Clearinghouse and a Patient Portal. The system is cloud-based and works with tablets, PCs, and smart phones.

“We are pleased that we can be part of the CTN mission of providing advanced information technologies and services for its members in order to provide high quality healthcare focusing on medically underserved and rural Californians,” said Dr. Sol Lizerbram, Chairman and co-founder of HealthFusion.

“HealthFusion serves thousands of medical practices including many smaller practices, so we believe we can make a significant contribution to the improvement of healthcare for all Californians, including those in rural areas,” Dr. Lizerbram concluded.

For more information, CTN members should visit the CTN Partners page at http://www.caltelehealth.org/partners.

California Telehealth Network

The mission of the California Telehealth Network is to promote advanced information technologies and services to improve access to high quality healthcare focusing on medically underserved and rural Californians. An independent non-profit 501c3, CTN has become one of the largest FCC-funded statewide telehealth networks in the nation, connecting over 750 healthcare provider locations. Additional funding has been provided by the California Emerging Technology Fund, the California HealthCare Foundation, the California Teleconnect Fund, the National Coalition for Health Integration, United HealthCare and the University of California. For more information, please visit www.caltelehealth.org or connect with CalTeleHealth on Facebook, Twitter and YouTube.

About HealthFusion

Founded in 1998, HealthFusion develops web-based, cloud computing software for physicians, hospitals and medical billing services. HealthFusion’s fully integrated solution includes MediTouch EHR (Electronic Health Record and Patient Portal) and MediTouch PM (Practice Management and Claims Clearinghouse). MediTouch EHR was designed for use on mobile tablets such as the iPad, and offers a unique array of features that facilitate adoption of EHR technology. Features include a mobile Pure Cloud platform, cross-compatibility with traditional desktop and laptop devices, and an affordable subscription payment model. MediTouch EHR is Meaningful Use 2014 Certified, and thousands of users throughout the country place their trust in HealthFusion and MediTouch every day. Healthcare is complicated; HealthFusion makes it easy. To learn more visit HealthFusion.com or follow HealthFusion on Facebook, Twitter and YouTube.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.